Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation
According to a story from prnewswire.com, the biopharmaceutical company Neurotech Pharmaceuticals recently announced that the company had earned Fast Track designation from the US Food and Drug Administration (FDA). This…